Shield Therapeutics plc

STX.L·LSE·Healthcare
Compare
3.4000−0.0500 (−1.45%)today
As of Nov 5, 9:34 AM GMT · May be delayed up to 15 min · GBX

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3.4500
Open3.4640
Day range3.40003.6000
52-week range2.926012.5000
Off day high−5.56%
Off 52-week high−72.80%
Volume2.90M
Avg. volume (3M)2.85M
Market cap36.52M
EPS (TTM)-0.0100
Forward P/E4.53
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)1.73
Shares outstanding1.07B
Short interest—
Earnings dateSep 2, 2025 (est.)
Analyst target16.6670
Profit margin−17.69%

Against its peers

Compare in full ›
STX.L MDP.TO RX.V IRWD CPH.TO SFZN.SW
Market cap 36.52M 158.39M 192.63M 622.95M 331.16M 3.27B
P/E (TTM) — — 20.2 4.9 8.5 19.1
Forward P/E 4.5 -252.0 30.6 2.5 — 15.9
Price/book -2.8 2.4 4.2 -3.9 1.7 3.3
Dividend yield — — 1.28% — — 0.53%
1-year change −55.80% +90.19% +59.24% +69.90% −12.08% +0.20%
Today −1.45% +1.41% +1.78% +7.71% −0.31% −0.27%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All STX.L news ›
AskTraders.com·Negative

Shield Therapeutics Drops 2026 Profit Target

Discover our top-rated, regulated brokers. Compare platforms, fees and features, and explore the latest broker offers. Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of…

TradingView·Positive

REG - Shield Therapeutics - Q3 2026 Trading Update

("Shield" or the "Company" or the "Group") Q3 commercial sales growth continues as Shield enters new phase of value creation with full US control of ACCRUFeR® Increase in net revenue with per prescription increase to $217 London, UK, 3…

From the 4Search news index, newest first.

In the news

3mentions in 30 days
3with it in the headline
Negativesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance